The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria
Abstract
BACKGROUND: Histamine-releasing activity (HRA) is detectable in up to 50% of patients with chronic ordinary urticaria. OBJECTIVES: To determine the effect of cyclosporin on clinical features and HRA in patients with chronic urticaria. METHODS: Thirty patients with severe unremitting disease, responding poorly to antihistamines and showing a positive autologous serum skin test (ASST) as a marker of HRA, were randomized to 4 mg kg-1 daily of cyclosporin (Sandimmun, n = 20) or placebo (n = 10) for 4 weeks. Non-responders were offered open-label cyclosporin for 4 weeks. All were followed for up to 20 weeks or until clinical relapse; all took cetirizine 20 mg daily throughout the study. The primary measure of efficacy was a daily urticaria activity score (UAS) of weal numbers and itch (maximum score 42 per week). A positive response was defined as a reduction to < 25% of baseline weekly UAS and relapse as a return to > 75%. The effect of cyclosporin on serum HRA was assessed by in vitro basophil histamine release assays and ASSTs before and after treatment. RESULTS: Twenty-nine patients (19 active, 10 controls) completed the randomized trial medication. Eight of 19 on active treatment but none on placebo had responded at 4 weeks (P < 0.05). Three others on active drug met the criterion for response at 2 weeks but not at 4 weeks. Mean reduction in UAS between weeks 0 and 4 was 12.7 (95% confidence interval, CI 6.6-18.8) for active and 2.3 (95% CI - 3.3-7.9) for placebo (P = 0.005). Seventeen non-responders (seven randomized to active and 10 to placebo) chose open-label cyclosporin and 11 responded after 4 weeks. Six of the eight randomized active drug responders relapsed within 6 weeks. Of the 19 responders to randomized and open-label cyclosporin, five (26%) had not relapsed by the study end-point. Mean in vitro serum HRA fell from 36% (95% CI 22-49%) to 5% (95% CI 1-8%) after cyclosporin treatment (n = 11, P < 0.0001). The ASST response to post-treatment serum was also reduced (P < 0.05). CONCLUSIONS: This study shows that cyclosporin is effective for chronic urticaria and provides further evidence for a role of histamine-releasing autoantibodies in the pathogenesis of this chronic 'idiopathic' disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions.
Plewis, I., & Fleiss, J. L. (1982) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982107 · Cited by 1,731
Hide, M., Francis, D. M., Grattan, C., Hakimi, J., Kochan, J. P., & Greaves, M. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282204 · Cited by 895
Self-citationFrison, L., & Pocock, S. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111304 · Cited by 593
Senn, S., Frison, L., & Pocock, S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130210 · Cited by 529
The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria
SABROE, GRATTAN, FRANCIS, BARR, BLACK, K., & GREAVES (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02707.x · Cited by 421
Niimi, N., Francis, D. M., Kermani, F., O'Donnell, B. F., Hide, M., Kobza-Black, A., Winkelmann, R. K., Greaves, M. W., & Barr, R. M. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12338544 · Cited by 312
Self-citationCovariate imbalance and random allocation in clinical trials
Senn, S. J. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080410 · Cited by 279
Hide, E. (1993) · Medical Entomology and Zoology · Cited by 267
Assessment of autoimmunity in patients with chronic urticaria
Tong, L. J., Balakrishnan, G., Kochan, J. P., Kinét, J.-P., & Kaplan, A. P. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70071-x · Cited by 248
Ferrer, M., Kinét, J.-P., & Kaplan, A. P. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70176-9 · Cited by 164
Anti-Inflammatory Effect of Cyclosporin A on Human Skin Mast Cells
Stellato, C., de Paulis, A., Ciccarelli, A., et al. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499960 · Cited by 155
Cirillo, R., Triggiani, M., Siri, L., Ciccarelli, A., Pettit, G. R., Condorelli, M., & Marone, G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.10.3891 · Cited by 144
Wershil, B. K., Furuta, G. T., Lavigne, J. A., Choudhury, A. R., Wang, Z. S., & Galli, S. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1391 · Cited by 93
MUNORO, C. S., Higgins, E. M., MARKS, J. M., Daly, B. M., Friedmann, P. S., & Shuster, S. (1991) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1991.tb03280.x · Cited by 77
Cited by
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A. H., Baker, D., Ballmer‐Weber, B., Bernstein, J. A., Bindslev‐Jensen, C., Brzoza, Z., Buense Bedrikow, R., et al. (2018) · Allergy · doi:10.1111/all.13397 · Cited by 1,445
Self-citationZuberbier, T., Abdul Latiff, A. H., Abuzakouk, M., Aquilina, S., Asero, R., Baker, D., Ballmer‐Weber, B., Bangert, C., Ben‐Shoshan, M., Bernstein, J. A., et al. (2022) · Allergy · doi:10.1111/all.15090 · Cited by 1,263
Self-citationZuberbier, T., Aberer, W., Asero, R., Bindslev‐Jensen, C., Brzoza, Z., Canonica, G. W., Church, M. K., Ensina, L. F., Giménez‐Arnau, A., Godse, K., et al. (2014) · Allergy · doi:10.1111/all.12313 · Cited by 1,203
Self-citationMaurer, M., Weller, K., Bindslev-Jensen, C., Giménez-Arnau, A., Bousquet, P. J., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E. H., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02496.x · Cited by 843
Self-citationThe diagnosis and management of acute and chronic urticaria: 2014 update
Bernstein, J. A., Lang, D. M., Khan, D. A., Craig, T., Dreyfus, D., Hsieh, F., Sheikh, J., Weldon, D., Zuraw, B., Bernstein, D. I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.036 · Cited by 682
Metadata
- Authors
- Grattan, C. E. H., O’Donnell, B. F., Francis, D. M., Niimi, N., Barlow, R. J., Seed, P. T., Kobza Black, A., & Greaves, M. W.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08
- Volume
- 143
- Issue
- 2
- Pages
- 365-372
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W1976551703
- Cited by
- 413
- References
- 14
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.